David Shaw’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

David Shaw’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-15,000	Closed	-$2.59M	–	4048
2015 Q1	$2.59M	Sell	15,000 -10,000	-40%	-$1.47M	﹤0.01%	1833
2014 Q4	$2.87M	Hold	25,000	–	–	﹤0.01%	1970
2014 Q3	$3.91M	Buy	25,000 +15,000	+150%	+$2.17M	0.01%	1736
2014 Q2	$1.23M	Hold	10,000	–	–	﹤0.01%	2744
2014 Q1	$1.04M	Sell	10,000 -10,000	-50%	-$1.02M	﹤0.01%	2998
2013 Q4	$1.8M	Hold	20,000	–	–	﹤0.01%	2629
2013 Q3	$1.34M	Buy	+20,000	New	+$1.38M	﹤0.01%	2778

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

David Shaw's SLXP Position: Q2 2015 in Review

David Shaw sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 258,455 shares — an estimated $44.7M sold.

David Shaw first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $44.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

David Shaw reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
David Shaw sold 258,455 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $44.7M.
David Shaw first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
David Shaw's SALIX PHARMACEUTICALS LTD DEL position peaked at $44.7M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.